The processing and presentation of lipids and glycolipids to the immune system

Immunological Reviews

Volumn 272, Issue 1, 2016, Pages 109-119

  Vartabedian, Vincent F ^a   Savage, Paul B ^b   Teyton, Luc ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Brigham Young University   (United States)

Author keywords

antigen presentation processing; CD1; lipid mediators; natural killer T cells; T cell receptors

Indexed keywords

CD1 ANTIGEN; CD1B ANTIGEN; CD1C ANTIGEN; CD1D ANTIGEN; GLYCOLIPID; LIPID; T6 ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN STRUCTURE; CRYSTAL STRUCTURE; ENDOSOME; IMMUNE SYSTEM; LIQUID CHROMATOGRAPHY; LYSOSOME; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYNTHESIS; TANDEM MASS SPECTROMETRY;

EID: 84975528318     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12431     Document Type: Review

References (98)

1. Castano AR, et al. Peptide binding and presentation by mouse CD1. Science 1995;269:223–226.
2. Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997;277:339–345.
3. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 1994;372:691–694.
4. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007;25:297–336.
5. Van Rhijn I, Ly D, Moody DB. CD1a, CD1b, and CD1c in immunity against mycobacteria. Adv Exp Med Biol 2013;783:181–197.
6. Calabi F, Milstein C. A novel family of human major histocompatibility complex-related genes not mapping to chromosome 6. Nature 1986;323:540–543.
7. Bradbury A, Belt KT, Neri TM, Milstein C, Calabi F. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J 1988;7:3081–3086.
8. Calabi F, Jarvis JM, Martin L, Milstein C. Two classes of CD1 genes. Eur J Immunol 1989;19:285–292.
9. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999;17:297–329.
10. Salomonsen J, et al. Two CD1 genes map to the chicken MHC, indicating that CD1 genes are ancient and likely to have been present in the primordial MHC. Proc Natl Acad Sci USA 2005;102:8668–8673.
11. Kasahara M. New insights into the genomic organization and origin of the major histocompatibility complex: role of chromosomal (genome) duplication in the emergence of the adaptive immune system. Hereditas 1997;127:59–65.
12. Dascher CC, et al. Conservation of a CD1 multigene family in the guinea pig. J Immunol 1999;163:5478–5488.
13. Borg ZD, et al. Polymorphisms in the CD1d promoter that regulate CD1d gene expression are associated with impaired NKT cell development. J Immunol 2014;192:189–199.
14. Zimmer MI, et al. Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells. Proc Natl Acad Sci USA 2009;106:1909–1914.
15. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506–512.
16. Zajonc DM, et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 2005;6:810–818.
17. Koch M, et al. The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol 2005;6:819–826.
18. Zajonc DM, Elsliger MA, Teyton L, Wilson IA. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2 15 A. Nat Immunol 2003;4:808–815.
19. Gadola SD, et al. Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol 2002;3:721–726.
20. Scharf L, et al. The 2.5 A structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 2010;33:853–862.
21. Garcia-Alles LF, et al. Crystal structure of human CD1e reveals a groove suited for lipid-exchange processes. Proc Natl Acad Sci USA 2011;108:13230–13235.
22. Kain L, et al. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 2014;41:543–554.
23. Yu ED, et al. Structural basis for the recognition of C20:2-alphaGalCer by the invariant natural killer T cell receptor-like antibody L363. J Biol Chem 2012;287:1269–1278.
24. Scott-Browne JP, et al. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat Immunol 2007;8:1105–1113.
25. Wang J, et al. Lipid binding orientation within CD1d affects recognition of Borrelia burgorferi antigens by NKT cells. Proc Natl Acad Sci USA 2010;107:1535–1540.
26. Van Rhijn I, et al. CD1d-restricted T cell activation by nonlipidic small molecules. Proc Natl Acad Sci USA 2004;101:13578–13583.
27. Van Rhijn I, Godfrey DI, Rossjohn J, Moody DB. Lipid and small-molecule display by CD1 and MR1. Nat Rev Immunol 2015;15:643–654.
28. de Jong A, et al. CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens. Nat Immunol 2014;15:177–185.
29. Bourgeois EA, et al. Bee venom processes human skin lipids for presentation by CD1a. J Exp Med 2015;212:149–163.
30. Moody DB, Zajonc DM, Wilson IA. Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 2005;5:387–399.
31. Cox D, et al. Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 2009;4:e5325.
32. Park JJ, et al. Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved. Proc Natl Acad Sci USA 2004;101:1022–1026.
33. Kim HS, Garcia J, Exley M, Johnson KW, Balk SP, Blumberg RS. Biochemical characterization of CD1d expression in the absence of beta2-microglobulin. J Biol Chem 1999;274:9289–9295.
34. Kang SJ, Cresswell P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J Biol Chem 2002;277:44838–44844.
35. Dougan SK, et al. Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells. J Exp Med 2005;202:529–539.
36. Sagiv Y, et al. A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d. J Exp Med 2007;204:921–928.
37. Zeissig S, et al. Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. J Clin Invest 2010;120:2889–2899.
38. Salio M, et al. Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc Natl Acad Sci USA 2007;104:20490–20495.
39. Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity 2001;15:897–908.
40. Rodionov DG, Nordeng TW, Pedersen K, Balk SP, Bakke O. A critical tyrosine residue in the cytoplasmic tail is important for CD1d internalization but not for its basolateral sorting in MDCK cells. J Immunol 1999;162:1488–1495.
41. Chiu YH, et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat Immunol 2002;3:55–60.
42. Elewaut D, et al. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells. J Exp Med 2003;198:1133–1146.
43. Cernadas M, et al. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J Immunol 2003;171:4149–4155.
44. Sloma I, et al. Regulation of CD1a surface expression and antigen presentation by invariant chain and lipid rafts. J Immunol 2008;180:980–987.
45. Chiu YH, et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 1999;189:103–110.
46. Sille FC, et al. Critical role for invariant chain in CD1d-mediated selection and maturation of Valpha14-invariant NKT cells. Immunol Lett 2011;139:33–41.
47. Sugita M, et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 1999;11:743–752.
48. Briken V, Jackman RM, Watts GF, Rogers RA, Porcelli SA. Human CD1b and CD1c isoforms survey different intracellular compartments for the presentation of microbial lipid antigens. J Exp Med 2000;192:281–288.
49. Sugita M, Cao X, Watts GF, Rogers RA, Bonifacino JS, Brenner MB. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 2002;16:697–706.
50. Briken V, Jackman RM, Dasgupta S, Hoening S, Porcelli SA. Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J 2002;21:825–834.
51. Sugita M, van Der Wel N, Rogers RA, Peters PJ, Brenner MB. CD1c molecules broadly survey the endocytic system. Proc Natl Acad Sci USA 2000;97:8445–8450.
52. Angenieux C, et al. The cellular pathway of CD1e in immature and maturing dendritic cells. Traffic 2005;6:286–302.
53. Zajonc DM, Wilson IA. Architecture of CD1 proteins. Curr Top Microbiol Immunol 2007;314:27–50.
54. Stern LJ. Characterizing MHC-associated peptides by mass spectrometry. J Immunol 2007;179:2667–2668.
55. Moody DB, et al. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation. Nat Immunol 2002;3:435–442.
56. McCarthy C, et al. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 2007;204:1131–1144.
57. Sandhoff K, Kolter T. Topology of glycosphingolipid degradation. Trends Cell Biol 1996;6:98–103.
58. Matsuo H, et al. Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 2004;303:531–534.
59. Gruenberg J. Lipids in endocytic membrane transport and sorting. Curr Opin Cell Biol 2003;15:382–388.
60. Schulze H, Kolter T, Sandhoff K. Principles of lysosomal membrane degradation: cellular topology and biochemistry of lysosomal lipid degradation. Biochim Biophys Acta 2009;1793:674–683.
61. Lev S. Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat Rev Mol Cell Biol 2010;11:739–750.
62. D'Angelo G, et al. Vesicular and non-vesicular transport feed distinct glycosylation pathways in the Golgi. Nature 2013;501:116–120.
63. Lauria I, et al. GLTP mediated non-vesicular GM1 transport between native membranes. PLoS ONE 2013;8:e59871.
64. Hanada K, et al. Molecular machinery for non-vesicular trafficking of ceramide. Nature 2003;426:803–809.
65. Mattner J, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005;434:525–529.
66. Gumperz JE, Brenner MB. CD1-specific T cells in microbial immunity. Curr Opin Immunol 2001;13:471–478.
67. Luoma AM, et al. Crystal structure of Vdelta1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human gammadelta T cells. Immunity 2013;39:1032–1042.
68. Zajonc DM, et al. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med 2005;202:1517–1526.
69. Gumperz JE, et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 2000;12:211–221.
70. Van Rhijn I, et al. Human autoreactive T cells recognize CD1b and phospholipids. Proc Natl Acad Sci USA 2016;113:380–385.
71. Kinjo Y, et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005;434:520–525.
72. Wieland Brown LC, et al. Production of alpha-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol 2013;11:e1001610.
73. Kawano T, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997;278:1626–1629.
74. Costantino V, Fattorusso E, Imperatore C, Mangoni A, Freigang S, Teyton L. Corrugoside, a new immunostimulatory alpha-galactoglycosphingolipid from the marine sponge Axinella corrugata. Bioorg Med Chem 2008;16:2077–2085.
75. Kinjo Y, et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011;12:966–974.
76. Kinjo Y, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006;7:978–986.
77. Brennan PJ, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011;12:1202–1211.
78. Brennan PJ, et al. Activation of iNKT cells by a distinct constituent of the endogenous glucosylceramide fraction. Proc Natl Acad Sci USA 2014;111:13433–13438.
79. Cao X, et al. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J Immunol 2002;169:4770–4777.
80. van den Elzen P, et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005;437:906–910.
81. Freigang S, et al. Scavenger receptors target glycolipids for natural killer T cell activation. J Clin Invest 2012;122:3943–3954.
82. Freigang S, et al. Fatty acid amide hydrolase shapes NKT cell responses by influencing the serum transport of lipid antigen in mice. J Clin Investig 2010;120:1873–1884.
83. Prigozy TI, et al. Glycolipid antigen processing for presentation by CD1d molecules. Science 2001;291:664–667.
84. de la Salle H, et al. Assistance of microbial glycolipid antigen processing by CD1e. Science 2005;310:1321–1324.
85. Darmoise A, et al. Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells. Immunity 2010;33:216–228.
86. Paduraru C, et al. Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition. Proc Natl Acad Sci USA 2013;110:5097–5102.
87. Zhou D, et al. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 2004;303:523–527.
88. Winau F, et al. Saposin C is required for lipid presentation by human CD1b. Nat Immunol 2004;5:169–174.
89. Kang SJ, Cresswell P. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat Immunol 2004;5:175–181.
90. Kolter T, Sandhoff K. Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol 2005;21:81–103.
91. Sandhoff K, Kolter T, Van Echten-Deckert G. Sphingolipid metabolism – sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell. Ann N Y Acad Sci 1998;845:139–151.
92. Alattia JR, Shaw JE, Yip CM, Prive GG. Direct visualization of saposin remodelling of lipid bilayers. J Mol Biol 2006;362:943–953.
93. Schrantz N, Sagiv Y, Liu Y, Savage PB, Bendelac A, Teyton L. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells. J Exp Med 2007;204:841–852.
94. Sagiv Y, et al. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein. J Immunol 2006;177:26–30.
95. da Silva RR, Dorrestein PC, Quinn RA. Illuminating the dark matter in metabolomics. Proc Natl Acad Sci USA 2015;112:12549–12550.
96. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005;4:594–610.
97. Gasa S, Nakamura M, Makita A, Ikura M, Hikichi K. Complete structural analysis of globoseries glycolipids by two-dimensional nuclear magnetic resonance. Eur J Biochem 1986;155:603–611.
98. Pettersen EF, et al. UCSF Chimera – a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605–1612.